Home » Newsletters » BioWorld

BioWorld

Feb. 19, 1993

View Archived Issues

SBIR FOR DRUG TO TREAT BRAIN DEATH

APPOINTMENTS AND ADVANCEMENTS

MULTINATIONAL HEPATITIS B TRIALS

VICAL GETS PATENT ALLOWANCE

HEMOSOL READIES PUBLIC OFFERING

BIOINSECTICIDE APPROVED IN MEXICO

FACTOR VIII-C PATENT UPHELD

CAUTIOUS RESPONSE TO CLINTON'S PLAN

CAMBRIDGE BIOTECH SEEKS TO PULL REGISTRATION

GROWTH HORMONE DESIGNATED ORPHAN DRUG

CEL-SCI PACT FOR MANUFACTURING PLANT

IBA MEMBERS RATIFY MERGER WITH ABC

CARTILAGE, BONE TISSUE GROWN IN VITRO

APPLIED BIOSYSTEMS MERGER OFFICIAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...